Cargando…
Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
BACKGROUND: Inadequate drug monitoring of drug therapy after hospital discharge facilitates adverse drug events and preventable hospital readmissions. OBJECTIVE: This study aimed to analyze the structure and content of drug monitoring advices of a representative sample of discharge letters as a basi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475819/ https://www.ncbi.nlm.nih.gov/pubmed/30958278 http://dx.doi.org/10.2196/10832 |
_version_ | 1783412810462527488 |
---|---|
author | Morath, Benedict Wien, Katharina Hoppe-Tichy, Torsten Haefeli, Walter Emil Seidling, Hanna Marita |
author_facet | Morath, Benedict Wien, Katharina Hoppe-Tichy, Torsten Haefeli, Walter Emil Seidling, Hanna Marita |
author_sort | Morath, Benedict |
collection | PubMed |
description | BACKGROUND: Inadequate drug monitoring of drug therapy after hospital discharge facilitates adverse drug events and preventable hospital readmissions. OBJECTIVE: This study aimed to analyze the structure and content of drug monitoring advices of a representative sample of discharge letters as a basis for future electronic information systems. METHODS: On 2 days in November 2016, all discharge letters of 3 departments of a university hospital were extracted from the hospital information system. The frequency, content, and structure of drug monitoring advices in discharge letters were investigated and compared with the theoretical monitoring requirements expressed in the corresponding summaries of product characteristics (SmPC). The quality of the drug monitoring advices in the discharge letters was rated with the domains of an adapted systematic instructions for monitoring (SIM) score. RESULTS: In total, 154 discharge letters were analyzed containing 1180 brands (240 active pharmaceutical substances), of which 50.42% (595/1180) could theoretically be amended with a monitoring advice according to the SmPC. In reality, 40 discharge letters (26.0%, 40/154) contained a total of 66 monitoring advices for 57 brands (4.83%, 57/1180), comprising 18 different monitoring parameters. Drug monitoring advices only addressed mean 1.9 (SD 0.8) of the 7 domains of the SIM score and frequently did not address reasons for monitoring (86%, 57/66), the timing of monitoring, that is, the start (76%, 50/66), the frequency (94%, 63/66), the stop (95%, 63/66), and how to react (83%, 55/66). CONCLUSIONS: Drug monitoring advices were mostly absent in discharge letters and a gold standard for appropriate drug monitoring advices was lacking. Hence, more effort should be put in the development of tools that facilitate easy presentation of clinically meaningful drug monitoring advices at the point of care. |
format | Online Article Text |
id | pubmed-6475819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-64758192019-05-08 Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development Morath, Benedict Wien, Katharina Hoppe-Tichy, Torsten Haefeli, Walter Emil Seidling, Hanna Marita JMIR Med Inform Original Paper BACKGROUND: Inadequate drug monitoring of drug therapy after hospital discharge facilitates adverse drug events and preventable hospital readmissions. OBJECTIVE: This study aimed to analyze the structure and content of drug monitoring advices of a representative sample of discharge letters as a basis for future electronic information systems. METHODS: On 2 days in November 2016, all discharge letters of 3 departments of a university hospital were extracted from the hospital information system. The frequency, content, and structure of drug monitoring advices in discharge letters were investigated and compared with the theoretical monitoring requirements expressed in the corresponding summaries of product characteristics (SmPC). The quality of the drug monitoring advices in the discharge letters was rated with the domains of an adapted systematic instructions for monitoring (SIM) score. RESULTS: In total, 154 discharge letters were analyzed containing 1180 brands (240 active pharmaceutical substances), of which 50.42% (595/1180) could theoretically be amended with a monitoring advice according to the SmPC. In reality, 40 discharge letters (26.0%, 40/154) contained a total of 66 monitoring advices for 57 brands (4.83%, 57/1180), comprising 18 different monitoring parameters. Drug monitoring advices only addressed mean 1.9 (SD 0.8) of the 7 domains of the SIM score and frequently did not address reasons for monitoring (86%, 57/66), the timing of monitoring, that is, the start (76%, 50/66), the frequency (94%, 63/66), the stop (95%, 63/66), and how to react (83%, 55/66). CONCLUSIONS: Drug monitoring advices were mostly absent in discharge letters and a gold standard for appropriate drug monitoring advices was lacking. Hence, more effort should be put in the development of tools that facilitate easy presentation of clinically meaningful drug monitoring advices at the point of care. JMIR Publications 2019-04-08 /pmc/articles/PMC6475819/ /pubmed/30958278 http://dx.doi.org/10.2196/10832 Text en ©Benedict Morath, Katharina Wien, Torsten Hoppe-Tichy, Walter Emil Haefeli, Hanna Marita Seidling. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 08.04.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on http://medinform.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Morath, Benedict Wien, Katharina Hoppe-Tichy, Torsten Haefeli, Walter Emil Seidling, Hanna Marita Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development |
title | Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development |
title_full | Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development |
title_fullStr | Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development |
title_full_unstemmed | Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development |
title_short | Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development |
title_sort | structure and content of drug monitoring advices included in discharge letters at interfaces of care: exploratory analysis preceding database development |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475819/ https://www.ncbi.nlm.nih.gov/pubmed/30958278 http://dx.doi.org/10.2196/10832 |
work_keys_str_mv | AT morathbenedict structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment AT wienkatharina structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment AT hoppetichytorsten structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment AT haefeliwalteremil structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment AT seidlinghannamarita structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment |